Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (231-240 of 467) with videos related to

Pageof 47
Sort By:
The Journal of Antimicrobial Chemotherapy|June 9, 2012
Immune recovery and T cell subset analysis during effective treatment with maravirocFrancesca Cossarini, Andrea Galli, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2018
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudySimone Belmonti, Francesca Lombardi, Eugenia Quiros-Roldan, et al.
AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.
Vaccine|October 11, 2025
Long-term protection and response to a booster dose after primary hepatitis B vaccination in people under pre-exposure prophylaxis for HIV infectionAngelo Roberto Raccagni, Giulia Morsica, Pierluigi Reali, et al.
The Journal of Infectious Diseases|September 24, 2025
Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIVMehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2024
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Tommaso Clemente, Sara Diotallevi, et al.
International Journal of Antimicrobial Agents|June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life settingTommaso Clemente, Laura Galli, Andrea Poli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2013
Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugsHamid Hasson, Marco Merli, Laura Galli, et al.
Eclinicalmedicine|December 8, 2025
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus dolutegravir as a two-drug regimen in adults naive to antiretroviral therapy (DYNAMIC): 24-week results from a randomised phase 2b studySamit R Joshi, Mar Masiá, Essack Mitha, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2020
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patientsFrancesco Saladini, Alessia Giannini, Federica Giammarino, et al.
Pageof 47

Showing results (231-240 of 467) with videos related to

Sort By:
Pageof 47
The Journal of Antimicrobial Chemotherapy|June 9, 2012
Immune recovery and T cell subset analysis during effective treatment with maravirocFrancesca Cossarini, Andrea Galli, Laura Galli, et al.
The Journal of Antimicrobial Chemotherapy|May 23, 2018
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudySimone Belmonti, Francesca Lombardi, Eugenia Quiros-Roldan, et al.
AIDS (London, England)|April 8, 2021
Residual viremia in HIV-infected patients who continue a two-drug or switch to a three-drug integrase strand transfer inhibitor based regimenNicola Gianotti, Laura Galli, Andrea Poli, et al.
Vaccine|October 11, 2025
Long-term protection and response to a booster dose after primary hepatitis B vaccination in people under pre-exposure prophylaxis for HIV infectionAngelo Roberto Raccagni, Giulia Morsica, Pierluigi Reali, et al.
The Journal of Infectious Diseases|September 24, 2025
Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIVMehdi Benlarbi, Jonathan Richard, Tommaso Clemente, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2024
Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life settingRebecka Papaioannu Borjesson, Tommaso Clemente, Sara Diotallevi, et al.
International Journal of Antimicrobial Agents|June 21, 2023
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life settingTommaso Clemente, Laura Galli, Andrea Poli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 29, 2013
Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugsHamid Hasson, Marco Merli, Laura Galli, et al.
Eclinicalmedicine|December 8, 2025
Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus dolutegravir as a two-drug regimen in adults naive to antiretroviral therapy (DYNAMIC): 24-week results from a randomised phase 2b studySamit R Joshi, Mar Masiá, Essack Mitha, et al.
The Journal of Antimicrobial Chemotherapy|May 29, 2020
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patientsFrancesco Saladini, Alessia Giannini, Federica Giammarino, et al.
Pageof 47